My ePortfolio Register   
Management of Chronic Lymphocytic Leukaemia in Older Patients

Management of Chronic Lymphocytic Leukaemia in Older Patients

en English

Complete this module today and earn yourself 1 CME Point.

Proceed to module  Shortlist  Rate Module  Share
Language

en English

Description

The information in this module is based on the published article:
'Management of Chronic Lymphocytic Leukemia: A position paper from the International Society of Geriatric Oncology'.
 

This module was published on 21st July 2017.

Target Audience

This module is for medical practitioners who wish to learn the SIOG guidelines for the management of chronic lymphocytic leukaemia in elderly patients.

Learning Objectives

By the end of this module, you should be able to understand:

  • The role of co-morbidity assessment, geriatric assessment and frailty screening in elderly patients with CLL.
  • The importance of prognostic factors in elderly patients with CLL.
  • The relevant predictive factors in elderly patients with CLL.
  • The initial treatment of elderly patients with CLL.
  • The treatment of elderly patients with recurrent CLL.
Accreditation

This module awards the learner 1 CME point upon successful completion and passing of the assessment. 

 

IT Requirements

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact info@ecancer.org and we will get back to you as soon as possible.

Commercial Support

Production of this module was funded by the International Society of Geriatric Oncology (SIOG) and by an unrestricted grant from Janssen.

Disclosure Policy

ecancer and Dr Alessandra Ferrajoli, Professor of Medicine Leukaemia, University of Texas M.D. Anderson Cancer Center, Texas, USA have no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this SIOG e-learning module which was made possible through an unrestricted educational grant from Janssen Pharmaceutical.

Proceed to Module

Relevant to the following professions

  • Nurse
  • Oncologist
  • Other
Proceed to module  Shortlist  Rate Module


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence